Authors:
JOYCE JN
GUREVICH EV
KUNG HF
KUNG MP
BORDELON Y
SHAPIRO R
ARNOLD SE
GUR RE
Citation: Jn. Joyce et al., DOPAMINE D3 RECEPTORS ARE ELEVATED IN SCHIZOPHRENIC BRAIN AND DECREASED BY NEUROLEPTIC TREATMENT, Schizophrenia research, 15(1-2), 1995, pp. 61-61
Authors:
FROHNA PA
ROTHBLAT DS
JOYCE JN
SCHNEIDER JS
Citation: Pa. Frohna et al., ALTERATIONS IN DOPAMINE UPTAKE SITES AND D1 AND D2 RECEPTORS IN CATS SYMPTOMATIC FOR AND RECOVERED FROM EXPERIMENTAL PARKINSONISM, Synapse, 19(1), 1995, pp. 46-55
Authors:
MURRAY AM
WEIHMUELLER FB
MARSHALL JF
HURTIG HI
GOTTLEIB GL
JOYCE JN
Citation: Am. Murray et al., DAMAGE TO DOPAMINE SYSTEMS DIFFERS BETWEEN PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE WITH PARKINSONISM, Annals of neurology, 37(3), 1995, pp. 300-312
Citation: Pa. Frohna et al., NEONATAL 6-HYDROXYDOPAMINE LESIONS LEAD TO OPPOSING CHANGES IN THE LEVELS OF DOPAMINE-RECEPTORS AND THEIR MESSENGER-RNAS, Neuroscience, 68(2), 1995, pp. 505-518
Citation: Jn. Joyce et P. Frohna, PARTIAL STRIATAL DA LOSS IN NEONATE PRODUCES IMMEDIATE AND LONG-TERM LOSS OF D1 RECEPTORS BUT ELEVATED MESSENGER-RNA, Developmental psychobiology, 28(3), 1995, pp. 188-188
Citation: Sk. Goldsmith et Jn. Joyce, ALTERATIONS IN HIPPOCAMPAL MOSSY FIBER PATHWAY IN SCHIZOPHRENIA AND ALZHEIMERS-DISEASE, Biological psychiatry, 37(2), 1995, pp. 122-126
Citation: Sk. Goldsmith et Jn. Joyce, DOPAMINE D2 RECEPTOR EXPRESSION IN HIPPOCAMPUS AND PARAHIPPOCAMPAL CORTEX OF RAT, CAT, AND HUMAN IN RELATION TO TYROSINE HYDROXYLASE-IMMUNOREACTIVE FIBERS, Hippocampus, 4(3), 1994, pp. 354-373
Authors:
LEXOW N
JOYCE JN
KIM SJ
PHILLIPS J
CASANOVA MF
BIRD ED
KLEINMAN JE
WINOKUR A
Citation: N. Lexow et al., ALTERATIONS IN TRH RECEPTORS IN TEMPORAL-LOBE OF SCHIZOPHRENICS - A QUANTITATIVE AUTORADIOGRAPHIC STUDY, Synapse, 18(4), 1994, pp. 315-327
Citation: J. Ulas et al., SELECTIVE INCREASE OF NMDA-SENSITIVE GLUTAMATE BINDING IN THE STRIATUM OF PARKINSONS-DISEASE, ALZHEIMERS-DISEASE, AND MIXED PARKINSONS-DISEASE ALZHEIMERS-DISEASE PATIENTS - AN AUTORADIOGRAPHIC STUDY, The Journal of neuroscience, 14(11), 1994, pp. 6317-6324
Citation: Am. Murray et al., LOCALIZATION OF DOPAMINE D-3 RECEPTORS TO MESOLIMBIC AND D-2 RECEPTORS TO MESOSTRIATAL REGIONS OF HUMAN FOREBRAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 91(23), 1994, pp. 11271-11275
Citation: Hl. Ryoo et Jn. Joyce, LOSS OF DOPAMINE D2 RECEPTORS VARIES ALONG THE ROSTROCAUDAL AXIS OF THE HIPPOCAMPAL COMPLEX IN ALZHEIMERS-DISEASE, Journal of comparative neurology, 348(1), 1994, pp. 94-110
Citation: Pa. Frohna et Jn. Joyce, DEVELOPMENTAL PLASTICITY OF THE DOPAMINE SYSTEMS IN THE RODENT BASAL GANGLIA, Biological psychiatry, 35(9), 1994, pp. 688-688
Citation: Jn. Joyce et Ev. Gurevich, [H-3] PAROXETINE BINDING IN HUMAN BRAIN - COMPARISON WITH [H-3] CYANOIMIPRAMINE, Biological psychiatry, 35(9), 1994, pp. 728-728
Citation: Jn. Joyce, THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - LIMBIC INTERACTIONS WITH SEROTONIN AND NOREPINEPHRINE, Psychopharmacology, 112(1), 1993, pp. 190000016-190000034
Citation: L. Rioux et Jn. Joyce, SUBSTANCE-P RECEPTORS ARE DIFFERENTIALLY AFFECTED IN PARKINSONS AND ALZHEIMERS-DISEASE, Journal of neural transmission. Parkinson's disease and dementia section, 6(3), 1993, pp. 199-210
Authors:
JOYCE JN
SHANE A
LEXOW N
WINOKUR A
CASANOVA MF
KLEINMAN JE
Citation: Jn. Joyce et al., SEROTONIN UPTAKE SITES AND SEROTONIN RECEPTORS ARE ALTERED IN THE LIMBIC SYSTEM OF SCHIZOPHRENICS, Neuropsychopharmacology, 8(4), 1993, pp. 315-336
Citation: Bs. Nealbeliveau et Jn. Joyce, D(1) AND D(2) DOPAMINE-RECEPTORS DO NOT UP-REGULATE IN RESPONSE TO NEONATAL INTRASTRIATAL 6-HYDROXYDOPAMINE LESIONS, Neuroscience letters, 160(1), 1993, pp. 77-80
Citation: Jn. Joyce et al., DOPAMINE D2 RECEPTORS IN THE HIPPOCAMPUS AND AMYGDALA IN ALZHEIMERS-DISEASE, Neuroscience letters, 154(1-2), 1993, pp. 171-174
Citation: Bs. Nealbeliveau et al., SEROTONERGIC INVOLVEMENT IN HALOPERIDOL-INDUCED CATALEPSY, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 207-217